174 related articles for article (PubMed ID: 31044527)
1. Fisetin activates Hippo pathway and JNK/ERK/AP-1 signaling to inhibit proliferation and induce apoptosis of human osteosarcoma cells via ZAK overexpression.
Fu CY; Chen MC; Tseng YS; Chen MC; Zhou Z; Yang JJ; Lin YM; Viswanadha VP; Wang G; Huang CY
Environ Toxicol; 2019 Aug; 34(8):902-911. PubMed ID: 31044527
[TBL] [Abstract][Full Text] [Related]
2. Selective Activation of ZAK β Expression by 3-Hydroxy-2-Phenylchromone Inhibits Human Osteosarcoma Cells and Triggers Apoptosis via JNK Activation.
Fu CY; Lay IS; Shibu MA; Tseng YS; Kuo WW; Yang JJ; Wang TF; Bharath BM; Yeh YL; Huang CY
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397561
[TBL] [Abstract][Full Text] [Related]
3. ZAK inhibits human lung cancer cell growth via ERK and JNK activation in an AP-1-dependent manner.
Yang JJ; Lee YJ; Hung HH; Tseng WP; Tu CC; Lee H; Wu WJ
Cancer Sci; 2010 Jun; 101(6):1374-81. PubMed ID: 20331627
[TBL] [Abstract][Full Text] [Related]
4. Effects of FOSL1 silencing on osteosarcoma cell proliferation, invasion and migration through the ERK/AP-1 signaling pathway.
Han Y; Zhao X; Sun Y; Sui Y; Liu J
J Cell Physiol; 2019 Apr; 234(4):3598-3612. PubMed ID: 30471098
[TBL] [Abstract][Full Text] [Related]
5. Emetine exerts anticancer effects in U2OS human osteosarcoma cells via activation of p38 and inhibition of ERK, JNK, and β-catenin signaling pathways.
Son J; Lee SY
J Biochem Mol Toxicol; 2021 Oct; 35(10):e22868. PubMed ID: 34338395
[TBL] [Abstract][Full Text] [Related]
6. The MAP3K ZAK, a novel modulator of ERK-dependent migration, is upregulated in colorectal cancer.
Rey C; Faustin B; Mahouche I; Ruggieri R; Brulard C; Ichas F; Soubeyran I; Lartigue L; De Giorgi F
Oncogene; 2016 Jun; 35(24):3190-200. PubMed ID: 26522728
[TBL] [Abstract][Full Text] [Related]
7. ELK1-induced upregulation of long non-coding RNA MIR100HG predicts poor prognosis and promotes the progression of osteosarcoma by epigenetically silencing LATS1 and LATS2.
Su X; Teng J; Jin G; Li J; Zhao Z; Cao X; Guo Y; Guo M; Li X; Wu J; Wang C; Guo Z; Guo Q
Biomed Pharmacother; 2019 Jan; 109():788-797. PubMed ID: 30551532
[TBL] [Abstract][Full Text] [Related]
8. RASSF5 inhibits growth and invasion and induces apoptosis in osteosarcoma cells through activation of MST1/LATS1 signaling.
Zhou XH; Yang CQ; Zhang CL; Gao Y; Yuan HB; Wang C
Oncol Rep; 2014 Oct; 32(4):1505-12. PubMed ID: 25109282
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin induces ZAKα overexpression with a subsequent enhancement of apoptosis and attenuation of survivability in human osteosarcoma cells.
Fu CY; Tseng YS; Chen MC; Hsu HH; Yang JJ; Tu CC; Lin YM; Viswanadha VP; Kuo WW; Huang CY
Environ Toxicol; 2018 Feb; 33(2):191-197. PubMed ID: 29105997
[TBL] [Abstract][Full Text] [Related]
10. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
Yang R; Piperdi S; Gorlick R
Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA URHC regulates cell proliferation and apoptosis via ZAK through the ERK/MAPK signaling pathway in hepatocellular carcinoma.
Xu WH; Zhang JB; Dang Z; Li X; Zhou T; Liu J; Wang DS; Song WJ; Dou KF
Int J Biol Sci; 2014; 10(7):664-76. PubMed ID: 25013376
[TBL] [Abstract][Full Text] [Related]
12. Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance.
Wang DY; Wu YN; Huang JQ; Wang W; Xu M; Jia JP; Han G; Mao BB; Bi WZ
Chin J Cancer; 2016 May; 35():47. PubMed ID: 27206784
[TBL] [Abstract][Full Text] [Related]
13. Identification of the ZAK-MKK4-JNK-TGFβ signaling pathway as a molecular target for novel synthetic iminoquinone anticancer compound BA-TPQ.
Chen D; Wang W; Qin JJ; Wang MH; Murugesan S; Nadkarni DH; Velu SE; Wang H; Zhang R
Curr Cancer Drug Targets; 2013 Jul; 13(6):651-60. PubMed ID: 23607596
[TBL] [Abstract][Full Text] [Related]
14. A novel synthetic derivative of the natural product berbamine inhibits cell viability and induces apoptosis of human osteosarcoma cells, associated with activation of JNK/AP-1 signaling.
Yang F; Nam S; Zhao R; Tian Y; Liu L; Horne DA; Jove R
Cancer Biol Ther; 2013 Nov; 14(11):1024-31. PubMed ID: 24025361
[TBL] [Abstract][Full Text] [Related]
15. Notch signaling regulates osteosarcoma proliferation and migration through Erk phosphorylation.
Qin J; Wang R; Zhao C; Wen J; Dong H; Wang S; Li Y; Zhao Y; Li J; Yang Y; He X; Wang D
Tissue Cell; 2019 Aug; 59():51-61. PubMed ID: 31383289
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of ZAKβ in human osteosarcoma cells enhances ZAKα expression, resulting in a synergistic apoptotic effect.
Fu CY; Tseng YS; Chen MC; Hsu HH; Yang JJ; Tu CC; Lin YM; Viswanadha VP; Ding K; Kuo WW; Huang CY
Cell Biochem Funct; 2018 Jun; 36(4):176-182. PubMed ID: 29654619
[TBL] [Abstract][Full Text] [Related]
17. ZAK induces cardiomyocyte hypertrophy and brain natriuretic peptide expression via p38/JNK signaling and GATA4/c-Jun transcriptional factor activation.
Hsieh YL; Tsai YL; Shibu MA; Su CC; Chung LC; Pai P; Kuo CH; Yeh YL; Viswanadha VP; Huang CY
Mol Cell Biochem; 2015 Jul; 405(1-2):1-9. PubMed ID: 25869677
[TBL] [Abstract][Full Text] [Related]
18. Kaempferol suppresses cell metastasis via inhibition of the ERK-p38-JNK and AP-1 signaling pathways in U-2 OS human osteosarcoma cells.
Chen HJ; Lin CM; Lee CY; Shih NC; Peng SF; Tsuzuki M; Amagaya S; Huang WW; Yang JS
Oncol Rep; 2013 Aug; 30(2):925-32. PubMed ID: 23708932
[TBL] [Abstract][Full Text] [Related]
19. Delphinidin induces apoptosis and inhibits epithelial-to-mesenchymal transition via the ERK/p38 MAPK-signaling pathway in human osteosarcoma cell lines.
Kang HM; Park BS; Kang HK; Park HR; Yu SB; Kim IR
Environ Toxicol; 2018 Jun; 33(6):640-649. PubMed ID: 29451351
[TBL] [Abstract][Full Text] [Related]
20. Fisetin Suppresses Human Osteosarcoma U-2 OS Cell Migration and Invasion
Chen JK; Peng SF; Lai KC; Liu HC; Huang YP; Lin CC; Huang AC; Chueh FS; Chung JG
In Vivo; 2019; 33(3):801-810. PubMed ID: 31028200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]